Global Medical Cannabis Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
USD Million/Billion
Loading…
Share Distribution
Loading…
Market Dynamics of Global Medical Cannabis Market Analysis
↑ Growth Drivers
Increasing patient demand and awareness
Growing research and development activities drive market growth
Advancements in technology fuels market expansion
↓ Restraints
High manufacturing costs limit market growth
Strict regulations can hinder market adoption
~ Trends
Rising mental health management sector
Growing investment and strategic collaborations
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Global Medical Cannabis Market Analysis — Presence
Interactive World Map
Click countries to explore
Loading map…
Regional and Country Analysis
North America — United States, Canada, Mexico
Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
Africa — East Africa, West Africa, North Africa, South Africa
Region / Country
2021 (A)
2025 (A)
2033 (P)
CAGR
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the Global Medical Cannabis Market Analysis
In no particular order of rank
Competitive Landscape of the Medical Cannabis Market
The market for medical cannabis is highly competitive, with a wide range of competitors, from well-known pharmaceutical firms to up-and-coming entrepreneurs, gaining market share; many businesses concentrate on developing innovative products, utilizing cutting-edge extraction technologies, and increasing their geographic reach. Furthermore, companies frequently engage in strategic alliances, mergers, and acquisitions as they work to fortify their portfolios and satisfy changing regulatory standards. Moreover, competition is encouraged in this dynamic environment, which leads to quality improvements, advances in research, and the creation of novel therapeutic applications to meet a range of consumer needs.
In February 2025, Cronos Group Inc. will add innovations to its Lord Jones® brand portfolio to strengthen its selection of high-end cannabis products in the Canadian market. The Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, which are currently offered all over Canada, include new cultivars. https://ir.thecronosgroup.com/news-releases/news-release-details/lord-jonesr-live-resin-vapes-and-ice-water-hash-pre-rolls-now In October 2024, Acreage Holdings, Inc. and Canopy Growth Corporation confirmed that Canopy USA, LLC has completed its acquisition of Acreage. Canopy USA now owns all of Acreage’s issued and outstanding shares. https://www.canopygrowth.com/investors/news-releases/canopy-growth-and-acreage-confirm-canopy-usas-completed-acquisition-of-acreage/ In November 2024, Medical Marijuana, Inc., the first publicly traded cannabis company in the United States to launch the world’s first cannabis-derived nutraceutical products, brands, and supply chain, announced that its subsidiary HempMeds® Mexico worked with experts from the Autonomous University of Barcelona, Spain, and the Meritorious Autonomous University of Puebla, Mexico, to conduct a new study that demonstrates the benefits of CBD in treating Parkinson’s disease. https://medicalmarijuanainc.com/2022/10/12/medical-marijuana-inc-subsidiary-hempmeds-mexico-participates-in-research-finding-promising-therapeutic-benefits-of-cbd-in-parkinsons-disease-treatment/
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Tilray Inc.
•••
•••
•••
•••
Canopy Growth
•••
•••
•••
•••
Aurora
•••
•••
•••
•••
GW Pharmaceuticals (Jazz Pharmaceuticals)
•••
•••
•••
•••
Green Thumb Industries
•••
•••
•••
•••
The Cronos Group
•••
•••
•••
•••
Trulieve
•••
•••
•••
•••
Cresco Labs
•••
•••
•••
•••
Medical Marijuana Inc.
•••
•••
•••
•••
Others
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
According to Cognitive Market Research, the global medical cannabis market size will be USD 21458.9 million in 2025. It will expand at a compound annual growth rate (CAGR) of 23.50% from 2025 to 2033.
North America held the major market share for more than 40% of the global revenue with a market size of USD 7939.79 million in 2025 and will grow at a compound annual growth rate (CAGR) of 22.1% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 6223.08 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 5150.14 million in 2025 and will grow at a compound annual growth rate (CAGR) of 26.5% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 815.44 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.9% from 2025 to 2033.
The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 858.36 million in 2025 and will grow at a compound annual growth rate (CAGR) of 24.1% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 472.10 million in 2025 and will grow at a compound annual growth rate (CAGR) of 23.1% from 2025 to 2033.
Mental health management category is the fastest-growing segment of the medical cannabis industry.
Introduction of the Medical Cannabis Market
Medical cannabis is cannabis that is used therapeutically to reduce the symptoms of a variety of illnesses. It usually consists of substances like tetrahydrocannabinol and cannabidiol, which are given under a doctor's supervision in controlled forms like oils, pills, and vaporized formulations. The medicinal cannabis industry is being driven by progressive regulatory improvements that enhance patient access and expand legalization. Moreover, the market is expanding as a result of rising patient demand for alternative therapies and increased confidence among medical professionals due to scientific studies verifying its therapeutic benefits. Furthermore, large investments in state-of-the-art farming and processing technologies are also creating opportunities for product innovation and diversity, creating a dynamic environment with a lot of opportunities for company growth.
The global medical cannabis market will expand significantly by 23.50% CAGR between 2025 and 2033.
Cannabidiol (CBD) is expected to dominate the medical cannabis market over the forecast period. Due to their wide range of therapeutic uses, low levels of psychoactivity, and safer, non-intoxicating qualities.
Neurological disorders management holds the largest market share in the distribution channel segment because of strong clinical evidence, the growing frequency of diseases like multiple sclerosis and epilepsy, and the growing use of cannabis-based treatments.
Analyst Conclusion
Conclusion
The global medical cannabis market will expand significantly by 23.50% CAGR between 2025 and 2033.
Cannabidiol (CBD) is expected to dominate the medical cannabis market over the forecast period. Due to their wide range of therapeutic uses, low levels of psychoactivity, and safer, non-intoxicating qualities.
Neurological disorders management holds the largest market share in the distribution channel segment because of strong clinical evidence, the growing frequency of diseases like multiple sclerosis and epilepsy, and the growing use of cannabis-based treatments.
Supriya Yadav
Research Analyst · Cognitive Market Research
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
The global market size for medical cannabis in 2025 is USD 21458.9 million.
The global medical cannabis market is expected to grow with a CAGR of 23.50% over the projected period.
North America held a significant global medical cannabis market revenue share in 2025.
Asia-Pacific will witness the fastest growth of the global medical cannabis market over the coming years.
The US had the most significant global medical cannabis market revenue share in 2025.
The main drivers of the growth of the medical cannabis market are the increasing clinical research therapeutic benefits, enhanced patient access, rising research and development, and supportive government policies.
The neurological disorders management category dominates the market.
★ Reviews
No reviews yet — be the first!
Rate this report
Global Medical Cannabis Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
19.6 Future Gross Margin Outlook and Profitability Trends
20.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
20.2 Analyst Point of View
20.3 Assumptions and Acronyms
21.1 Primary Data Collection
21.1.1 Steps for Primary Data Collection
21.1.1.1 Identification of KOL
21.1.2 Backward Integration
21.1.3 Forward Integration
21.1.4 How Primary Research Help Us
21.1.5 Modes of Primary Research
21.2 Secondary Research
21.2.1 How Secondary Research Help Us
21.2.2 Sources of Secondary Research
21.3 Data Validation
21.3.1 Data Triangulation
21.3.2 Top Down & Bottom Up Approach
21.3.3 Cross check KOL Responses with Secondary Data
21.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Medical Cannabis Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Medical Cannabis Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global medical cannabis market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
